|
1
|
Hunt SA, Baker DW, Chin MH, Cinquegrani
MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G,
Jessup ML, et al: ACC/AHA Guidelines for the evaluation and
management of chronic heart failure in the adult: Executive summary
a report of the American college of cardiology/american heart
association task force on practice guidelines (Committee to Revise
the 1995 Guidelines for the Evaluation and Management of Heart
Failure): Developed in collaboration with the international society
for heart and lung transplantation; endorsed by the heart failure
society of America. Circulation. 104:2996–3007. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Owan TE, Hodge DO, Herges RM, Jacobsen SJ,
Roger VL and Redfield MM: Trends in prevalence and outcome of heart
failure with preserved ejection fraction. N Engl J Med.
355:251–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhatia RS, Tu JV, Lee DS, Austin PC, Fang
J, Haouzi A, Gong Y and Liu PP: Outcome of heart failure with
preserved ejection fraction in a population-based study. N Engl J
Med. 355:260–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gradman AH and Alfayoumi F: From left
ventricular hypertrophy to congestive heart failure: Management of
hypertensive heart disease. Prog Cardiovasc Dis. 48:326–341. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lopaschuk GD, Ussher JR, Folmes CD, Jaswal
JS and Stanley WC: Myocardial fatty acid metabolism in health and
disease. Physiol Rev. 90:207–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paolisso G, Gambardella A, Galzerano D,
D'Amore A, Rubino P, Verza M, Teasuro P, Varricchio M and D'Onofrio
F: Total-body and myocardial substrate oxidation in congestive
heart failure. Metabolism. 43:174–179. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ross PL, Huang YN, Marchese JN, Williamson
B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, et
al: Multiplexed protein quantitation in Saccharomyces cerevisiae
using amine-reactive isobaric tagging reagents. Mol Cell
Proteomics. 3:1154–1169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th.
National Academies Press; Washington, DC: 2011
|
|
9
|
Dixon IM, Lee SL and Dhalla NS:
Nitrendipine binding in congestive heart failure due to myocardial
infarction. Circ Res. 66:782–788. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang B, Li Y, Zhao L, Yuan S, Wang Z, Li B
and Chen Q: Stable isotope dimethyl labeling combined with LTQ mass
spectrometric detection, a quantitative proteomics technology used
in liver cancer research. Biomed Rep. 1:549–554. 2013.PubMed/NCBI
|
|
11
|
de Carvalho HF and Taboga SR: Fluorescence
and confocal laser scanning microscopy imaging of elastic fibers in
hematoxylin-eosin stained sections. Histochem Cell Biol.
106:587–592. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
VanBuren P, Harris DE, Alpert NR and
Warshaw DM: Cardiac V1 and V3 myosins differ in their hydrolytic
and mechanical activities in vitro. Circ Res. 77:439–444. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shibayama J, Yuzyuk TN, Cox J, Makaju A,
Miller M, Lichter J, Li H, Leavy JD, Franklin S and Zaitsev AV:
Metabolic remodeling in moderate synchronous versus dyssynchronous
pacing-induced heart failure: Integrated metabolomics and
proteomics study. PLoS One. 10:e01189742015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Andresen BS, Olpin S, Poorthuis BJ,
Scholte HR, Vianey-Saban C, Wanders R, Ijlst L, Morris A,
Pourfarzam M, Bartlett K, et al: Clear correlation of genotype with
disease phenotype in very-long-chain acyl-CoA dehydrogenase
deficiency. Am J Hum Genet. 64:479–494. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osorio JC, Stanley WC, Linke A, Castellari
M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD and Recchia FA:
Impaired myocardial fatty acid oxidation and reduced protein
expression of retinoid X receptor-alpha in pacing-induced heart
failure. Circulation. 106:606–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nikolaidis LA, Sturzu A, Stolarski C,
Elahi D, Shen YT and Shannon RP: The development of myocardial
insulin resistance in conscious dogs with advanced dilated
cardiomyopathy. Cardiovasc Res. 61:297–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allard MF, Schonekess BO, Henning SL,
English DR and Lopaschuk GD: Contribution of oxidative metabolism
and glycolysis to ATP production in hypertrophied hearts. Am J
Physiol. 267:H742–H750. 1994.PubMed/NCBI
|
|
18
|
Heather LC, Cole MA, Lygate CA, Evans RD,
Stuckey DJ, Murray AJ, Neubauer S and Clarke K: Fatty acid
transporter levels and palmitate oxidation rate correlate with
ejection fraction in the infarcted rat heart. Cardiovasc Res.
72:430–437. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sack MN, Rader TA, Park S, Bastin J,
McCune SA and Kelly DP: Fatty acid oxidation enzyme gene expression
is downregulated in the failing heart. Circulation. 94:2837–2842.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lei B, Lionetti V, Young ME, Chandler MP,
d'Agostino C, Kang E, Altarejos M, Matsuo K, Hintze TH, Stanley WC
and Recchia FA: Paradoxical downregulation of the glucose oxidation
pathway despite enhanced flux in severe heart failure. J Mol Cell
Cardiol. 36:567–576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rosca MG, Vazquez EJ, Kerner J, Parland W,
Chandler MP, Stanley W, Sabbah HN and Hoppel CL: Cardiac
mitochondria in heart failure: Decrease in respirasomes and
oxidative phosphorylation. Cardiovasc Res. 80:30–39. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sihag S, Cresci S, Li AY, Sucharov CC and
Lehman JJ: PGC-1alpha and ERRalpha target gene downregulation is a
signature of the failing human heart. J Mol Cell Cardiol.
46:201–212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barger PM, Brandt JM, Leone TC, Weinheimer
CJ and Kelly DP: Deactivation of peroxisome proliferator-activated
receptor-alpha during cardiac hypertrophic growth. J Clin Invest.
105:1723–1730. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Morgan EE, Chandler MP, Young ME,
McElfresh TA, Kung TA, Rennison JH, Tserng KY, Hoit BD and Stanley
WC: Dissociation between gene and protein expression of metabolic
enzymes in a rodent model of heart failure. Eur J Heart Fail.
8:687–693. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bers DM: Altered cardiac myocyte Ca
regulation in heart failure. Physiology (Bethesda). 21:380–387.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hobai IA and O'Rourke B: Decreased
sarcoplasmic reticulum calcium content is responsible for defective
excitation-contraction coupling in canine heart failure.
Circulation. 103:1577–1584. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piacentino V III, Weber CR, Chen X,
Weisser-Thomas J, Margulies KB, Bers DM and Houser SR: Cellular
basis of abnormal calcium transients of failing human ventricular
myocytes. Circ Res. 92:651–658. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanaka M, Müllauer L, Ogiso Y, Fujita H,
Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T and
Kuzumaki N: Gelsolin: A candidate for suppressor of human bladder
cancer. Cancer Res. 55:3228–3232. 1995.PubMed/NCBI
|
|
29
|
McGough AM, Staiger CJ, Min JK and
Simonetti KD: The gelsolin family of actin regulatory proteins:
Modular structures, versatile functions. FEBS Lett. 552:75–81.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nishio R and Matsumori A: Gelsolin and
cardiac myocyte apoptosis: A new target in the treatment of
postinfarction remodeling. Circ Res. 104:829–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li GH, Shi Y, Chen Y, Sun M, Sader S,
Maekawa Y, Arab S, Dawood F, Chen M, de Couto G, et al: Gelsolin
regulates cardiac remodeling after myocardial infarction through
DNase I-mediated apoptosis. Circ Res. 104:896–904. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja
D, Namkung Y, Shin HS and Chiamvimonvat N: Functional roles of
Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: Insight
gained using gene-targeted null mutant mice. Circ Res. 90:981–987.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Z, He Y, Tuteja D, Xu D, Timofeyev
V, Zhang Q, Glatter KA, Xu Y, Shin HS, Low R and Chiamvimonvat N:
Functional roles of Cav1.3(alpha1D) calcium channels in atria:
Insights gained from gene-targeted null mutant mice. Circulation.
112:1936–1944. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Petrone AB, Weir NL, Steffen BT, Tsai MY,
Gaziano JM and Djousse L: Plasma vitamin D-binding protein and risk
of heart failure in male physicians. Am J Cardiol. 112:827–830.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guha C, Osawa M, Werner PA, Galbraith RM
and Paddock GV: Regulation of human Gc (vitamin D-binding) protein
levels: Hormonal and cytokine control of gene expression in vitro.
Hepatology. 21:1675–1681. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Petrini M, Galbraith RM, Werner PA,
Emerson DL and Arnaud P: Gc (vitamin D binding protein) binds to
cytoplasm of all human lymphocytes and is expressed on B-cell
membranes. Clin Immunol Immunopathol. 31:282–295. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gomme PT and Bertolini J: Therapeutic
potential of vitamin D-binding protein. Trends Biotechnol.
22:340–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chun RF: New perspectives on the vitamin D
binding protein. Cell Biochem Funct. 30:445–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Christakos S, Ajibade DV, Dhawan P,
Fechner AJ and Mady LJ: Vitamin D: Metabolism. Endocrinol Metab
Clin North Am. 39:243–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kongsbak M, von Essen MR, Levring TB,
Schjerling P, Woetmann A, Odum N, Bonefeld CM and Geisler C:
Vitamin D-binding protein controls T cell responses to vitamin D.
BMC Immunol. 15:352014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Safadi FF, Thornton P, Magiera H, Hollis
BW, Gentile M, Haddad JG, Liebhaber SA and Cooke NE: Osteopathy and
resistance to vitamin D toxicity in mice null for vitamin D binding
protein. J Clin Invest. 103:239–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bikle DD, Gee E, Halloran B, Kowalski MA,
Ryzen E and Haddad JG: Assessment of the free fraction of
25-hydroxyvitamin D in serum and its regulation by albumin and the
vitamin D-binding protein. J Clin Endocrinol Metab. 63:954–959.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Haddad JG, Fraser DR and Lawson DE:
Vitamin D plasma binding protein. Turnover and fate in the rabbit.
J Clin Invest. 67:1550–1560. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Weishaar RE and Simpson RU: Vitamin D3 and
cardiovascular function in rats. J Clin Invest. 79:1706–1712. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weishaar RE, Kim SN, Saunders DE and
Simpson RU: Involvement of vitamin D3 with cardiovascular function.
III. Effects on physical and morphological properties. Am J
Physiol. 258:E134–E142. 1990.PubMed/NCBI
|
|
46
|
Dorsch MP, Nemerovski CW, Ellingrod VL,
Cowger JA, Dyke DB, Koelling TM, Wu AH, Aaronson KD, Simpson RU and
Bleske BE: Vitamin D receptor genetics on extracellular matrix
biomarkers and hemodynamics in systolic heart failure. J Cardiovasc
Pharmacol Ther. 19:439–445. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pilz S, Mürz W, Wellnitz B, Seelhorst U,
Fahrleitner-Pammer A, Dimai HP, Boehm BO and Dobnig H: Association
of vitamin D deficiency with heart failure and sudden cardiac death
in a large cross-sectional study of patients referred for coronary
angiography. J Clin Endocrinol Metab. 93:3927–3935. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nadal-Ginard B and Mahdavi V: Molecular
basis of cardiac performance. Plasticity of the myocardium
generated through protein isoform switches. J Clin Invest.
84:1693–1700. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nakao K, Minobe W, Roden R, Bristow MR and
Leinwand LA: Myosin heavy chain gene expression in human heart
failure. J Clin Invest. 100:2362–2370. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Abraham WT, Gilbert EM, Lowes BD, Minobe
WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA,
Wolfel EE, et al: Coordinate changes in Myosin heavy chain isoform
gene expression are selectively associated with alterations in
dilated cardiomyopathy phenotype. Mol Med. 8:750–760.
2002.PubMed/NCBI
|
|
51
|
Machackova J, Barta J and Dhalla NS:
Myofibrillar remodeling in cardiac hypertrophy, heart failure and
cardiomyopathies. Can J Cardiol. 22:953–968. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dhalla NS, Saini-Chohan HK,
Rodriguez-Leyva D, Elimban V, Dent MR and Tappia PS: Subcellular
remodelling may induce cardiac dysfunction in congestive heart
failure. Cardiovasc Res. 81:429–438. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Machackova J, Sanganalmath SK, Elimban V
and Dhalla NS: β-adrenergic blockade attenuates cardiac dysfunction
and myofibrillar remodelling in congestive heart failure. J Cell
Mol Med. 15:545–554. 2011. View Article : Google Scholar : PubMed/NCBI
|
